Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated
Alexandra M. Stevens(Baylor College of Medicine), Michele S. Redell(Baylor College of Medicine)
Cited by 18
Related Papers
DOT1L Inhibition Sensitizes MLL-Rearranged AML to Chemotherapy
|PLoS ONE|2014|73
Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia
|Clinical & Translational Oncology|2021|8